We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+16.88%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.03B
AUM Growth
-$287M
Cap. Flow
-$398M
Cap. Flow %
-38.68%
Top 10 Hldgs %
14.04%
Holding
1,478
New
335
Increased
269
Reduced
346
Closed
503

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$12.3M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$10.9M
3
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$10.4M
4
TSLA icon
Tesla
TSLA
+$9.96M
5
NVDA icon
NVIDIA
NVDA
+$8.73M

Top Sells

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$10.4M
2
AVGO icon
Broadcom
AVGO
+$9.33M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$8.68M
4
DESP
Despegar.com
DESP
+$7.15M
5
ORCL icon
Oracle
ORCL
+$6.74M

Sector Composition

Rank Sector Weight
1 Technology 18.86%
2 Consumer Discretionary 12.74%
3 Healthcare 12.34%
4 Communication Services 10.34%
5 Industrials 8.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MTD icon
1226
Mettler-Toledo International
MTD
$28.6B
– –
-383
Closed -$452K
MTB icon
1227
M&T Bank
MTB
$36.2B
– –
-2,833
Closed -$506K
MUB icon
1228
iShares National Muni Bond ETF
MUB
$45.9B
– –
-3,570
Closed -$376K
MX icon
1229
Magnachip Semiconductor
MX
$145M
– –
-16,619
Closed -$57K
NAT icon
1230
Nordic American Tanker
NAT
$1.37B
– –
-20,954
Closed -$51.5K
NBIX icon
1231
Neurocrine Biosciences
NBIX
$16.6B
– –
-2,132
Closed -$236K
NETD
1232
DELISTED
Nabors Energy Transition Corp II
NETD
– –
-19,231
Closed -$211K
NFG icon
1233
National Fuel Gas
NFG
$7.65B
– –
-3,587
Closed -$284K
NFLX icon
1234
PUT
Netflix
NFLX
$309B
– –
-10,000
Closed -$933K
NGVT icon
1235
Ingevity
NGVT
$2.68B
– –
-5,203
Closed -$206K
NI icon
1236
CALL
NiSource
NI
$20.4B
– –
-32,800
Closed -$1.31M
NKTR icon
1237
Nektar Therapeutics
NKTR
$2.58B
– –
-44,677
Closed -$456K
NOA
1238
North American Construction
NOA
$395M
– –
-174,991
Closed -$2.76M
NTAP icon
1239
NetApp
NTAP
$37.2B
– –
-2,514
Closed -$221K
NTES icon
1240
NetEase
NTES
$84.7B
– –
-34,599
Closed -$3.56M
NTRS icon
1241
Northern Trust
NTRS
$33.9B
– –
-2,635
Closed -$260K
NVAX icon
1242
Novavax
NVAX
$1.31B
– –
-19,213
Closed -$123K
NVMI
1243
Nova
NVMI
$12.5B
– –
-3,228
Closed -$595K
NWBI icon
1244
Northwest Bancshares
NWBI
$2.28B
– –
-11,508
Closed -$138K
NWSA icon
1245
News Corp Class A
NWSA
$15.4B
– –
-15,464
Closed -$421K
NXRT
1246
NexPoint Residential Trust
NXRT
$652M
– –
-33,158
Closed -$1.31M
NXST icon
1247
Nexstar Media Group
NXST
$5.97B
– –
-2,010
Closed -$360K
O icon
1248
PUT
Realty Income
O
$59.1B
– –
-12,100
Closed -$702K
TEAD
1249
Teads Holding Co
TEAD
$67.7M
– –
-26,620
Closed -$99.3K
OC icon
1250
Owens Corning
OC
$12.4B
– –
-2,568
Closed -$367K
48 49
50
51 52

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, Prelude Capital Management held 1,478 positions worth $1.03B, down 22% from $1.32B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Prelude Capital Management withdrew a net $398M in Q2 2025, closing 503 positions and reducing 346 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $10.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Prelude Capital Management opened a new position in Alphabet (Google) Class C worth $11.7M.

  • Prelude Capital Management's largest Q2 2025 buy was Alphabet (Google) Class C: 65,723 shares worth $11.7M.
  • Prelude Capital Management added most to Meta Platforms (Facebook) in Q2 2025, an estimated $12.3M increase.
  • Prelude Capital Management's biggest Q2 2025 reduction was Broadcom, cutting an estimated $9.33M.
  • Prelude Capital Management fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $10.4M.
  • Prelude Capital Management's ten largest holdings make up 14% of its $1.03B portfolio in Q2 2025.
  • Prelude Capital Management opened 335 new positions and closed 503 in Q2 2025.
  • Prelude Capital Management's portfolio value fell 22% quarter-over-quarter to $1.03B.

Based on Prelude Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.